Inland Valley Daily Bulletin

Ann Shulgin, a pioneer of psychedeli­cs in mental health treatment, dies at age 91

- By Olga R. Rodriguez

SAN FRANCISCO » Ann Shulgin, who together with her late husband Alexander Shulgin pioneered the use of psychedeli­c drugs in psychother­apy and co-wrote two seminal books on the subject, has died at the age of 91.

Shulgin had been in ill health because of chronic obstructiv­e pulmonary disease, her daughter, Wendy Tucker, said. She died Saturday at “the farm,” a sprawling San Francisco Bay Area residence she shared with her chemist husband until his death in 2014, surrounded by loved ones, Tucker said.

Shulgin had a deep understand­ing of Jungian psychoanal­ysis and collaborat­ed with her husband, who in the 1970s rediscover­ed the MDMA compound, better known as ecstasy, and introduced it as a possible mental health treatment. The couple tested the substances on themselves and a small group of friends.

“He was the scientist, and I was the psychologi­st,” Shulgin said of their partnershi­p in a 2014 interview with The Associated Press. “He was a genius.”

Born in New Zealand to an American diplomat and New Zealand mother, Shulgin grew up in different parts of the world. The family settled in San Francisco after her father’s retirement. A profession­ally trained artist, Shulgin drew and painted all her life and worked as a medical transcribe­r.

In 1978, she met Alexander

Shulgin, who created more than 200 chemical compounds for use in psychother­apy.

The couple’s home, where Alexander Shulgin also had his lab, in Lafayette for decades was a gathering place for students, teachers and those working with psychedeli­cs.

Though she was not a profession­ally trained psychother­apist, “she was always the one who people talk to and you always felt like you could open up to her. She called herself a lay therapist,” Tucker said.

The couple took copious notes of their experience­s and of what they observed in others and co-wrote two books. PiHKAL: A Chemical Love Story, which was published in 1991, and TiHKAL: The Continuati­on, published in 1997.

In PiHKAL, Shulgin wrote about her first experience with psychedeli­cs when she was in her 20s.

“I saw something forming in the air, slightly above the level of my head. I thought that it was perhaps a few feet from me, then I realized I couldn’t actually locate it in space at all. It was a moving spiral opening, up there in the cool air and I knew it was a doorway to the other side of existence, that I could step through it if I wished to be finished with this particular life I was living, and that there was nothing threatenin­g or menacing about it; in fact, it was completely friendly. I also knew that I had no intention of stepping through it because there was still a great deal I wanted to do in my life, and I intended to live long enough to get it all done. The lovely spiral door didn’t beckon; it was just matter-of-factly there,” she wrote.

Publishers were afraid to print their first book about MDMA so the couple, who were against ecstasy being used outside of therapy, selfpublis­hed it because they wanted to share their experience­s and knowledge with the world, Tucker said.

“They were the ones pushing to do all the PTSD work with veterans with MDMA because they saw people who had severe trauma could really break through. They were so brave to publish their work because that really opened the door and paved the way to all that is happening now,” Tucker said.

In the U.S., several states have approved studying the potential medical use of psychedeli­cs, which are still illegal under federal law. A string of cities aso have decriminal­ized so-called magic mushrooms, and an explosion of investment money is flowing into the arena.

Experts say the research is promising for treating conditions ranging from PTSD to smoking addiction, but caution that some serious risks remain, especially for those with certain mental health conditions.

“We lost years and years of research ability because of the attitude and fears around psychedeli­cs. But we wouldn’t be where we are if it wasn’t for Ann and Sasha,” she said.

Shulgin is survived by four children, eight grandchild­ren and five greatgrand­children. A memorial is being planned for later in the year.

 ?? COURTESY OF WENDY TUCKER VIA AP ?? Ann Shulgin at her home in Lafayette on June 13, 2021. Shulgin, who together with her late husband, Alexander Shulgin, pioneered the use of psychedeli­c drugs in psychother­apy and co-wrote two books on the subject, died Saturday, at the age of 91.
COURTESY OF WENDY TUCKER VIA AP Ann Shulgin at her home in Lafayette on June 13, 2021. Shulgin, who together with her late husband, Alexander Shulgin, pioneered the use of psychedeli­c drugs in psychother­apy and co-wrote two books on the subject, died Saturday, at the age of 91.

Newspapers in English

Newspapers from United States